Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1199 of 5804
-
Can a 14-Minute video curb suicidal thoughts? new study tests 'Papageno' approach
Symptom relief CompletedThe purpose of this study is to determine the effects of a short "Papageno story" video of a compilation of interviews on proximal risk factors for suicide. The researchers believe that the intervention may increase protective factors related to suicide.
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a stronger flu shot protect lung transplant patients better?
Disease control Recruiting nowThis will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-0014) at Vanderbilt University Medical Center. Lung transplantation is a life-saving therapy for patients with advanced …
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
AI guides Surgeons' knives in landmark safety trial
Symptom relief Recruiting nowToday, the majority of gallbladder removals surgeries are done using minimally invasive techniques through small cuts to help patients recover faster. However, these procedures are technically more challenging because surgeons have a restricted view of the patient's anatomy, whic…
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Psychedelic combo trial aims to ease PTSD in veterans
Symptom relief Recruiting nowThe purpose of this study is to assess the safety and effectiveness of co-administered MDMA and psilocybin in military Veterans with a diagnosis of Posttraumatic Stress Disorder (PTSD). To apply or learn more, please view our website: https://hopkinspsychedelic.org/pamvet
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New combo tackles liver cancer when standard treatment stops working
Disease control Recruiting nowAtezolizumab plus bevacizumab is the first-line treatment for advanced hepatocellular carcinoma (HCC). However, the effect of the second-line treatment after the progress of Atezolizumab plus bevacizumab therapy remains unsatisfactory. This is a prospective trial to investigate t…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
HIV prevention on wheels: PrEP pills offered on mobile van for drug users
Prevention CompletedFor this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
Phase: PHASE4 • Sponsor: Duke University • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
New drug aims to tame COPD Flare-Ups in Hard-to-Treat patients
Disease control Recruiting nowThis is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pul…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New eye drops aim to soothe Sjögren's dry eye
Symptom relief Recruiting nowrhPRG4-Sjögren's-002 is a prospective multi-center study conducted in Australia to evaluate the safety and efficacy of topically-applied rhPRG4 in subjects with Sjögren's related Dry Eye Disease.
Phase: PHASE2 • Sponsor: Lubris Bio Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New drug avelumab aims to keep upper tract cancer at bay after chemo
Disease control Recruiting nowA Prospective Phase II Study of Adjuvant Cisplatin-Based Chemotherapy followed by Maintenance Avelumab in Upper Tract Urothelial Carcinoma
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New patch could ease agitation for Alzheimer's patients
Symptom relief Recruiting nowThe primary objective of this study is to evaluate the efficacy of DMTS on frequency and severity of agitation associated with dementia of the Alzheimer's type, compared with placebo.
Phase: PHASE2 • Sponsor: Teikoku Pharma USA, Inc. • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New hope for Hard-to-Treat cancers: targeted drug enters human testing
Disease control Recruiting nowThis is an open-label, multi-center phase I clinical study to evaluate HRS-6093 Safety, Tolerability, and Pharmacokinetics in Participants harboring KRAS G12D Mutations with advanced solid tumors. The study consists of dose escalation, dose expansion and efficacy expansion.
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New peptide drug PQ203 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThe primary purposes of this study are to determine the safety and tolerability of PQ203 in patients with advanced solid tumors including triple negative breast cancer (TNBC), and to determine a recommended Phase 2 dose level for future studies in TNBC.
Phase: PHASE1 • Sponsor: ProteinQure Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New light probe aims to prevent thyroid surgery complication
Disease control Recruiting nowThis is a prospective, single-blinded, randomized controlled trial to evaluate whether PTeye™ can reduce post-operative hypoparathyroidism (PH). The study will enroll consecutive patients undergoing total thyroidectomy in a teritary endocrine surgery unit in Hong Kong, randomizin…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
AI stethoscope? new study uses smart tech to spot hidden heart danger
Diagnosis ENROLLING_BY_INVITATIONThe DETECT-AS Diagnostic Study will assess the performance of artificial intelligence (AI) risk predictions to detect aortic stenosis using results from portable electrocardiogram (ECG) and cardiac ultrasound devices.
Phase: NA • Sponsor: Yale University • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Houston program aims to break cycle of gun violence after injury
Disease control Recruiting nowA prior violent injury is one of the strongest predictors of future violent injury, highlighting the importance of effective hospital-based interventions to prevent reinjury. This project will establish and evaluate the Houston Hospital-Based Violence Intervention Program (Housto…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a drug for schizophrenia work differently in men and women?
Symptom relief Recruiting nowSchizophrenia differs between sexes in clinical symptoms and functional outcome. Negative symptoms are the core pathology of this disease. NMDA receptor (NMDAR) dysfunction is a key factor in negative symptoms. This study aims to examine the sex difference in the efficacy of an N…
Phase: PHASE2 • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 18:32 UTC
-
HIV prevention shots coming to your local pharmacy?
Prevention OngoingThis is an open-label, single center study to evaluate implementation of a pharmacist-managed delivery of L4P in a community pharmacy setting and the impact of twice-yearly vs. quarterly PrEP visits on STI rates.
Phase: PHASE4 • Sponsor: Kelley-Ross & Associates, Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
New drug duo takes on tough lung cancer
Disease control Recruiting nowThe primary objective for dose exploration and dose expansion is to evaluate the safety and tolerability of tarlatamab in combination with AB248. The primary objective for dose exploration only is to determine the recommended dose for expansion and/or maximum tolerated combinati…
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to help patients shed pounds after failed weight-loss surgery
Disease control Recruiting nowThis clinical trial aims to evaluate the weight-loss efficacy and safety of efsubaglutide alfa in patients who remain obese 6 months after metabolic surgery.
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New pill targets hard-to-treat cancers with KRAS mutation
Disease control Recruiting nowThe goal of this trial is to learn if KQB548 works to treat patients with advanced solid malignancies with a KRAS G12D mutation. It will also learn about the safety of KQB548. The main questions it aims to answer are: * What is the safe dose of KQB548? * Does KQB548 decrease the…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC